What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Gene
His primary areas of study are Angiogenesis, Cancer research, Vascular endothelial growth factor, Internal medicine and Pathology.
His Angiogenesis study combines topics from a wide range of disciplines, such as Colorectal cancer, Metastasis, Transfection and Cell growth.
The Cancer research study combines topics in areas such as Tumor progression, Growth factor receptor inhibitor, Cell culture and Combination therapy.
His research on Vascular endothelial growth factor focuses in particular on Vascular endothelial growth factor A.
His studies in Internal medicine integrate themes in fields like Gastroenterology, Endocrinology and Oncology.
His Pathology research includes themes of Epithelial–mesenchymal transition, Pancreatic cancer and Pseudopodia.
His most cited work include:
- Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and Angiogenesis (2214 citations)
- Drug development: Raise standards for preclinical cancer research (1815 citations)
- Recurrence and Outcomes Following Hepatic Resection, Radiofrequency Ablation, and Combined Resection/Ablation for Colorectal Liver Metastases (1379 citations)
What are the main themes of his work throughout his whole career to date?
Lee M. Ellis spends much of his time researching Cancer research, Internal medicine, Colorectal cancer, Angiogenesis and Vascular endothelial growth factor.
Lee M. Ellis combines subjects such as Cell culture, Pancreatic cancer, Cell growth, Cancer cell and Immunology with his study of Cancer research.
He has included themes like Gastroenterology, Endocrinology and Oncology in his Internal medicine study.
As part of the same scientific family, Lee M. Ellis usually focuses on Colorectal cancer, concentrating on Surgery and intersecting with Radiofrequency ablation.
His Angiogenesis research focuses on Metastasis and how it relates to Pathology.
His Vascular endothelial growth factor research includes elements of Receptor, Growth factor receptor inhibitor and Transfection.
He most often published in these fields:
- Cancer research (35.76%)
- Internal medicine (33.41%)
- Colorectal cancer (28.47%)
What were the highlights of his more recent work (between 2013-2021)?
- Colorectal cancer (28.47%)
- Cancer research (35.76%)
- Internal medicine (33.41%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Colorectal cancer, Cancer research, Internal medicine, Cancer and Oncology.
His studies deal with areas such as Gene knockdown, Cell growth, Carcinogenesis, Immunology and Primary tumor as well as Colorectal cancer.
Lee M. Ellis has researched Cancer research in several fields, including Endothelial stem cell, Paracrine signalling, Phenotype, Cancer stem cell and microRNA.
His research in Endothelial stem cell intersects with topics in Bevacizumab, Stromal cell and Vascular endothelial growth factor.
The various areas that Lee M. Ellis examines in his Cancer study include Biomarker, Pharmacology and Small interfering RNA.
Lee M. Ellis has researched Oncology in several fields, including Cetuximab, Chemotherapy and Cohort.
Between 2013 and 2021, his most popular works were:
- Antiangiogenic therapy in oncology: current status and future directions. (393 citations)
- American Society of Clinical Oncology Perspective: Raising the Bar for Clinical Trials by Defining Clinically Meaningful Outcomes (260 citations)
- Colon cancer cells escape 5FU chemotherapy-induced cell death by entering stemness and quiescence associated with the c-Yes/YAP axis (161 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Gene
Lee M. Ellis focuses on Colorectal cancer, Cancer research, Clinical trial, Cancer and Cell growth.
In general Colorectal cancer study, his work on Oxaliplatin often relates to the realm of Proinflammatory cytokine, thereby connecting several areas of interest.
His works in Vascular endothelial growth factor and Angiogenesis are all subjects of inquiry into Cancer research.
His study explores the link between Clinical trial and topics such as Intensive care medicine that cross with problems in Drug development, Biomarker, Pharmacology and Combination therapy.
His research integrates issues of Molecular biology and Pathology in his study of Cancer.
In his study, Neoadjuvant therapy, Cell, Chemotherapy and Gene is strongly linked to Cancer cell, which falls under the umbrella field of Cell growth.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
